MedPath

Safety Evaluation of Advantage Anti-Caries Varnish

Phase 1
Completed
Conditions
Dental Caries
Interventions
Drug: Varnish
Registration Number
NCT02645617
Lead Sponsor
Advantage Dental Services, LLC
Brief Summary

The purpose of the study is to confirm the safety of Advantage Anti-Caries Varnish.

Detailed Description

This is an open-label Phase 1 study. The active ingredients are Povidone Iodine and Sodium Fluoride \[Therametrics Technologies, Inc, Noblesville, IN, USA\]. The oral soft tissues and teeth of the children will be examined and the test varnish to the teeth. The child will be re-examined at 24-48 hours for the presence of adverse oral soft tissue changes. At the follow-up, a qualified dental provider will ask questions focused on adverse events.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Healthy
Exclusion Criteria
  • Weight less than 15 kg or hypersensitivity to iodine

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
VarnishVarnishDental varnish containing povidone iodine and sodium fluoride
Primary Outcome Measures
NameTimeMethod
Soft Tissuewithin 48 hours

Proportion of participants with any oral ulcerations OR inflammatory response

Secondary Outcome Measures
NameTimeMethod
Adverse Eventswithin 48 hours

Proportion of participants with any emergency medical care OR report of nausea OR not eating OR vomiting OR difficulty swallowing OR swelling around the mouth OR itchiness around the mouth OR hives OR rash OR stomach ache OR diarrhea

Trial Locations

Locations (1)

University of Washington Regional Clinical Dental Research Center

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath